Alliance - Home

OUR VISION

The Alliance for Clinical Trials in Oncology seeks to reduce the impact of cancer by uniting a broad community of scientists and clinicians who are committed to the prevention and treatment of cancer.

The Alliance has been awarded a grant by the National Cancer Institute (NCI) as a member of the NCI National Clinical Trials Network (NCTN).

TRIBUTE: DANIEL J. SARGENT, PHD, ALLIANCE GROUP STATISTICIAN

We invite you to remember Daniel J. Sargent's legacy. Please visit our memorial page and submit a special tribute or remembrance to tribute@alliancenctn.org, and we will post it.

UPCOMING MEETINGS

IN THE NEWS

December 20, 2024 - Happy Holidays
December 12, 2024 - Alliance Foundation Trials Phase III PATINA Study Shows Promise for Patients with HR+, HER2+ Metastatic Breast Cancer
December 11, 2024 - New Trial Alert: PROSPECT-Lung Trial | Non-small Cell Lung Cancer
November 25, 2024 - New Trial Alert: Alliance A092205 Recurrent or Metastatic Head and Neck Cancer
November 25, 2024 - Alliance Elects New Group Vice-Chair
October 29, 2024 - Alliance Group Statistician Co-Chairs Working Group Whose Recommendations Define a "New Normal" for Data Collection and Published in the Journal of the National Cancer Institute
October 23, 2024 - MyeloMATCH Precision Medicine Trials in Myeloid Leukemias Open to Patient Enrollment Across the U.S. and Canada
October 23, 2024 - 2024 Alliance Fall Hybrid Group Meeting Convenes October 30-November 1

View More

OUR VISION

TRIBUTE: DANIEL J. SARGENT, PHD, ALLIANCE GROUP STATISTICIAN

New PROSPECT-Lung Trial Launches to Advance Treatment Options for Operable Non-Small Cell Lung Cancer

UPCOMING MEETINGS

IN THE NEWS

ALLIANCE ON SOCIAL

FROM THE NCI